Compare CRCT & ORIC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CRCT | ORIC |
|---|---|---|
| Founded | 1969 | 2014 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Wholesale Distributors | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 904.7M | 861.3M |
| IPO Year | 2021 | 2020 |
| Metric | CRCT | ORIC |
|---|---|---|
| Price | $4.14 | $8.51 |
| Analyst Decision | Strong Sell | Strong Buy |
| Analyst Count | 1 | 13 |
| Target Price | $3.00 | ★ $19.73 |
| AVG Volume (30 Days) | 498.9K | ★ 1.0M |
| Earning Date | 05-05-2026 | 05-05-2026 |
| Dividend Yield | ★ 22.20% | N/A |
| EPS Growth | ★ 20.69 | 19.67 |
| EPS | ★ 0.10 | N/A |
| Revenue | ★ $708,780,000.00 | N/A |
| Revenue This Year | $0.08 | N/A |
| Revenue Next Year | $0.98 | N/A |
| P/E Ratio | $41.35 | ★ N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $3.74 | $7.23 |
| 52 Week High | $7.33 | $14.93 |
| Indicator | CRCT | ORIC |
|---|---|---|
| Relative Strength Index (RSI) | 49.51 | 39.95 |
| Support Level | $3.83 | $7.83 |
| Resistance Level | $4.26 | $11.22 |
| Average True Range (ATR) | 0.16 | 0.43 |
| MACD | 0.01 | 0.07 |
| Stochastic Oscillator | 43.38 | 48.22 |
Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.
ORIC Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It has a pipeline of therapies designed to counter resistance mechanisms in cancer by leveraging its expertise within three specific areas: hormone-dependent cancers, precision oncology, and key tumor dependencies. The company has product candidates namely ORIC-944, ORIC-114, and ORIC-533. The Company has as one operating segment, focused on the discovery and development of therapies designed to counter the resistance mechanisms in cancer.